Filing Details

Accession Number:
0000914475-13-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-24 19:32:00
Reporting Period:
2013-06-20
Filing Date:
2013-06-24
Accepted Time:
2013-06-24 19:32:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
914475 Neurocrine Biosciences Inc NBIX Biological Products, (No Disgnostic Substances) (2836) 330525145
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343124 Flint Christopher Obrien Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego CA 92130
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-20 5,000 $12.45 94,794 No 4 S Direct
Common Stock Disposition 2013-06-20 5,000 $12.37 94,794 No 4 S Direct
Common Stock Disposition 2013-06-20 10,000 $12.20 94,794 No 4 S Direct
Common Stock Disposition 2013-06-20 1,217 $12.56 94,794 No 4 S Direct
Common Stock Disposition 2013-06-21 5,000 $12.50 94,794 No 4 S Direct
Common Stock Disposition 2013-06-21 1,143 $13.01 94,794 No 4 S Direct
Common Stock Disposition 2013-06-21 8,783 $12.58 94,794 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option Acquisiton 2013-06-20 10,000 $8.92 10,000 $8.92
Common Stock Incentive Stock Option Acquisiton 2013-06-20 1,217 $8.92 1,217 $8.92
Common Stock Incentive Stock Option Acquisiton 2013-06-21 8,783 $8.92 8,783 $8.92
Common Stock Nonstatutory Stock Option Acquisiton 2013-06-20 5,000 $5.12 5,000 $5.12
Common Stock Nonstatutory Stock Option Acquisiton 2013-06-20 1,143 $5.12 1,143 $5.12
Common Stock Incentive Stock Option Acquisiton 2013-06-20 5,000 $2.59 5,000 $2.59
Common Stock Incentive Stock Option Acquisiton 2013-06-21 5,000 $2.59 5,000 $2.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,500 2007-11-14 2013-11-14 No 4 X Direct
16,283 2007-11-14 2013-11-14 No 4 X Direct
7,500 2007-11-14 2013-11-14 No 4 X Direct
25,000 2009-02-27 2015-02-27 No 4 X Direct
23,857 2009-02-27 2015-02-27 No 4 X Direct
165,000 2010-06-11 2017-05-11 No 4 X Direct
160,000 2010-06-11 2017-05-11 No 4 X Direct
Footnotes
  1. Exercise of in-the-money or at-the-money derivative security
  2. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
  3. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.40 to $12.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.32 to $12.40. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.32. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  6. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.51 to $12.72. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  7. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.53. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  8. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  9. Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.75. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.